Therapy and Monitoring

Neurological Cancer

The 5-year survival rate for people with cancerous brain or CNS tumors is 34 percent for men and 36 percent for women.⁷ GE Healthcare’s technology helps to improve visualization and analytical monitoring of disease progression or response to therapy.⁸

Products

MR_Product Listing Image_2020_320x180_3T_PETMR

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

OncoQuant

Robust tools for routine Oncology diagnosis, treatment follow-up, reporting and clinical trial management.

READY View

Quantified MR image analysis to enable accurate, confident diagnoses.

Products

CT Perfusion 4D Neuro

Quick, automatic & complete tissue assessment for treatment confidence. All the functionnal information you need… Now.

References:

7. https://www.cancer.net/cancer-types/brain-tumor/statistics

8. https://www.gehealthcare.com/en/products/advanced-visualization/all-applications/pet-vcar

JB04823XX